| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.037 | 0.8 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.044 | 0.8 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |